Yavuz S, Abraham T, Houtsmuller A, van Royen M
Cells. 2024; 13(20.
PMID: 39451211
PMC: 11506798.
DOI: 10.3390/cells13201693.
Chen H, Zhou Y, Wang X, Chai X, Wang Z, Wang E
Adv Sci (Weinh). 2024; 11(19):e2309261.
PMID: 38481034
PMC: 11109662.
DOI: 10.1002/advs.202309261.
Heim T, Hankins M, Belayneh R, Douglas N, Dinh V, Kovvur M
Oncogene. 2024; 43(14):1007-1018.
PMID: 38361046
PMC: 10978487.
DOI: 10.1038/s41388-024-02957-x.
Ren S, Li J, Dorado J, Sierra A, Gonzalez-Diaz H, Duardo A
Health Inf Sci Syst. 2023; 12(1):6.
PMID: 38125666
PMC: 10728428.
DOI: 10.1007/s13755-023-00264-5.
Li Q, Zhu J, Zhang Y, Pan Y, Li Z, Wang M
Sci Rep. 2023; 13(1):21629.
PMID: 38062230
PMC: 10703870.
DOI: 10.1038/s41598-023-48906-8.
Sleep apnea syndrome associated with gonadal hormone imbalance (Review).
Cojocaru C, Cojocaru E, Pohaci-Antonesei L, Pohaci-Antonesei C, Dumitrache-Rujinski S
Biomed Rep. 2023; 19(6):101.
PMID: 38025832
PMC: 10646762.
DOI: 10.3892/br.2023.1683.
Advances in bio-immunotherapy for castration-resistant prostate cancer.
Lin C, Chen Y, Shi L, Lin H, Xia H, Yin W
J Cancer Res Clin Oncol. 2023; 149(14):13451-13458.
PMID: 37460807
DOI: 10.1007/s00432-023-05152-9.
Pueraria lobata Potentially Treating Prostate Cancer on Single-Cell Level by Network Pharmacology and AutoDock: Clinical Findings and Drug Targets.
Mo Y, Chen M, Qin H, Liu H, Ye Y
Comput Math Methods Med. 2022; 2022:3758219.
PMID: 36452480
PMC: 9705089.
DOI: 10.1155/2022/3758219.
Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors.
Radaeva M, Li H, Leblanc E, Dalal K, Ban F, Ciesielski F
Cells. 2022; 11(18).
PMID: 36139361
PMC: 9497135.
DOI: 10.3390/cells11182785.
Androgen Receptor-Mediated Transcription in Prostate Cancer.
Ozturan D, Morova T, Lack N
Cells. 2022; 11(5).
PMID: 35269520
PMC: 8909478.
DOI: 10.3390/cells11050898.
Role of Sex Hormones at Different Physiobiological Conditions and Therapeutic Potential in MBD2 Mediated Severe Asthma.
Wasti B, Chen Z, He Y, Duan W, Liu S, Xiang X
Oxid Med Cell Longev. 2022; 2021:7097797.
PMID: 35096261
PMC: 8799366.
DOI: 10.1155/2021/7097797.
Sex and gender in respiratory physiology.
LoMauro A, Aliverti A
Eur Respir Rev. 2021; 30(162).
PMID: 34750114
PMC: 9488190.
DOI: 10.1183/16000617.0038-2021.
Transcriptome and Methylome Analysis Reveal Complex Cross-Talks between Thyroid Hormone and Glucocorticoid Signaling at Xenopus Metamorphosis.
Buisine N, Grimaldi A, Jonchere V, Rigolet M, Blugeon C, Hamroune J
Cells. 2021; 10(9).
PMID: 34572025
PMC: 8468809.
DOI: 10.3390/cells10092375.
Glycosylation: Rising Potential for Prostate Cancer Evaluation.
Kaluza A, Szczykutowicz J, Ferens-Sieczkowska M
Cancers (Basel). 2021; 13(15).
PMID: 34359624
PMC: 8345048.
DOI: 10.3390/cancers13153726.
The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance.
Cronin R, Brooke G, Prischi F
Oncogene. 2021; 40(22):3775-3785.
PMID: 33972681
PMC: 8175238.
DOI: 10.1038/s41388-021-01810-9.
Lipogenic effects of androgen signaling in normal and malignant prostate.
Mah C, Nassar Z, Swinnen J, Butler L
Asian J Urol. 2020; 7(3):258-270.
PMID: 32742926
PMC: 7385522.
DOI: 10.1016/j.ajur.2019.12.003.
Endocrine regulation of lung disease and inflammation.
Fuentes N, Silveyra P
Exp Biol Med (Maywood). 2018; 243(17-18):1313-1322.
PMID: 30509139
PMC: 6348592.
DOI: 10.1177/1535370218816653.
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
Joshi J, Patel D, Morton D, Sharma P, Zou J, Hewa Bostanthirige D
Mol Oncol. 2017; 11(4):337-357.
PMID: 28252832
PMC: 5378613.
DOI: 10.1002/1878-0261.12028.
Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer.
Erzurumlu Y, Ballar P
Sci Rep. 2017; 7:40719.
PMID: 28091582
PMC: 5238502.
DOI: 10.1038/srep40719.
Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
Chattopadhyay I, Wang J, Qin M, Gao L, Holtz R, Vessella R
Oncotarget. 2017; 8(6):10324-10347.
PMID: 28055971
PMC: 5354662.
DOI: 10.18632/oncotarget.14401.